BA
Biren Amin Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $15 |
19%
downside
| Neutral | 1 month ago |
|
2
BridgeBio Pharma
BBIO
$9.91B
| $51.83 | $68 |
31%
upside
| Overweight | 1 month ago |
|
3
Solid Biosciences
SLDB
$433M
| $5.56 | $17 |
206%
upside
| Overweight | 3 months ago |
|
|
LENZ
4
LENZ Therapeutics
LENZ
$1.14B
| $39.92 | $51 |
28%
upside
| Overweight | 4 months ago |
|
|
CNTA
5
Centessa Pharmaceuticals
CNTA
$2.12B
| $15.79 | $38 |
141%
upside
| Overweight | 5 months ago |
|
6
Compass Therapeutics
CMPX
$466M
| $3.37 | $12 |
256%
upside
| Overweight | 6 months ago |
|
7
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $71 |
168%
upside
| Overweight | 7 months ago |
|
8
Immunome
IMNM
$853M
| $9.80 | $21 |
114%
upside
| Overweight | 9 months ago |
|
9
Arcellx
ACLX
$4B
| $72.16 | $115 |
59%
upside
| Overweight | 10 months ago |
|
10
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $32 |
12%
upside
| Neutral | 10 months ago |
|
11
Ocular Therapeutix
OCUL
$2.21B
| $12.70 | $15 |
18%
upside
| Overweight | 1 year ago |
|
12
Aldeyra Therapeutics
ALDX
$332M
| $5.53 | $24 |
334%
upside
| Buy | 4 years ago |
|
13
Taysha Gene Therapies
TSHA
$889M
| $3.26 | $34 |
943%
upside
| Buy | 4 years ago |
|
14
Immatics
IMTX
$695M
| $5.72 | $14 |
145%
upside
| Buy | 5 years ago |
|
15
Regeneron Pharmaceuticals
REGN
$60.1B
| $567.22 | $691 |
22%
upside
| Buy | 5 years ago |
|
16
CytomX Therapeutics
CTMX
$346M
| $2.10 | $10 |
376%
upside
| Hold | 5 years ago |
|